Jump to content

Advocacy Opportunity / EGFR: see details within post


Recommended Posts

Fellow patient and writer Annabelle Gurwitch is writing about her experiences with insurance coverage for her gene mutation targeted medication. She'd love to speak with you and asked us to reach out on her behalf. She is especially interested in covering the topic of third-party copay maximizers. She is also interested in speaking to anyone who is on Medicaid and receiving a targeted therapy, and your experiences with insurance coverage.

Please email Nikki Martin, Senior Director, Precision Medicine Initiatives (nmartin@lungevity.org) who will connect you with Annabelle.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.